Topical formulation for administering a compound
USRE47034E1 · kind E1 · reissue
2Cited by
2References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2017 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | May 24, 2037 |
Classification
- Technology area (CPC —)General
Abstract
Embodiments of topical formulations for administering compound I or a pharmaceutically acceptable salt or solvate thereof are disclosed. Embodiments of methods for using the topical formulations in the treatment of dermatological disorders such as cutaneous collagen vascular diseases, e.g., cutaneous lupus, also are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.